Philip E. Shih

Philip E. Shih

Auto-generated profile, based on publicly available information

Philip E. Shih

Department of Radiology and Biomedical Imaging, University of California, San Francisco, USA; UCSF-UC Berkeley Joint Medical Program, Berkeley, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2025 in Journal of Clinical Neuroscience
Verified
Journal Article
Open access
PSPhilip E. Shih
Philip E. Shih
RORobert C. Osorio
Robert C. Osorio
LLLynn Leng
Lynn Leng
BLBlanca Morales Lugo
Blanca Morales Lugo
SGShiv Gupta
Shiv Gupta
MAManish K. Aghi
Manish K. Aghi
Pituitary neuroendocrine tumors (PitNETs), also known as pituitary adenomas, are typically hypoenhancing and rarely display hyperenhancement on post-contrast T1-weighted MRI. The frequency and significance of this hyperenhancement has not been studied. We conducted a retrospective review on PitNET transsphenoidal surgeries performed at a high-volume pituitary center from 2012 to 2019. Tumor hyperenhancement was defined by neuroradiologist impression of preoperative brain MRIs with contrast. Preoperative covariates included patient age, sex, number of prior pituitary surgeries, endocrine symptoms, tumor size, cavernous sinus invasion, and tumor functional vs nonfunctional status. Postoperative variables included tumor Ki-67 rating, extent of resection, incidence of postoperative transient and permanent diabetes insipidus (DI), and need for adjuvant radiation therapy. Correlation with hyperenhancement was assessed with Pearson's chi-squared, Fisher's exact, and Wilcoxon rank-sum tests, where appropriate. Dichotomous and numeric variables with p < 0.1 were included in a multiple regression analysis to assess confounding. 836 patients were identified with PitNETs who underwent transsphenoidal resection. Among these, 14 tumors (1.67 %) demonstrated contrast hyperenhancement on preoperative MRI. Hyperenhancing tumors were more commonly microadenomas (43 % vs 19 %, p = 0.034). On multiple regression analysis, hyperenhancing tumors were more commonly associated with postoperative transient DI (odds ratio 2.80, 95 % confidence interval 1.09-6.36, p = 0.019). On univariate and multiple regression, all other tumor characteristics and outcomes were unaltered by hyperenhancement. Hyperenhancing PitNETs are a rare finding on preoperative post-contrast T1-weighted MRI imaging (1.67 % prevalence) and carry 2.8 × higher odds of postoperative transient diabetes insipidus after surgical resection (OR 2.80, 95 % CI 1.09-6.36, p = 0.019). Surgical teams may consider additional approaches to preserving the pituitary stalk and postoperative monitoring for dysnatremia to minimize postoperative risk of diabetes insipidus.

23 September 2026 in Parkinsonism & Related Disorders
Verified
Journal Article
Open access
DSDevin Schoen
Devin Schoen
PSPhilip Shih
Philip Shih
LWLucia West
Lucia West
SDSkyler Deutsch
Skyler Deutsch
JMJuhi Mehta
Juhi Mehta
MMMelanie A. Morrison
Melanie A. Morrison
Diffusion-based tractography has been used to predict deep brain stimulation (DBS) outcomes in Parkinson's disease (PD), but the predictive value of fractional anisotropy (FA) maps, which can be generated with far less computation, remains underexplored. We retrospectively analyzed preoperative diffusion MRI from 143 patients with PD who underwent DBS between 2013 and 2023. Whole-brain and tract-specific FA measures were extracted and evaluated against the pre-to-postoperative change in levodopa equivalent daily dose (ΔLEDD). Nested regression models compared clinical predictors alone with models that added whole-brain FA or stability-selected tract-specific FA. Tract-specific FA explained an additional 2.3-3.4% of ΔLEDD variance (p = 0.038), whereas whole-brain FA did not (p = 0.497); effects were in the same direction, though smaller and no longer significant, after adjustment for gold-standard motor response to dopaminergic medications. The uncinate fasciculus and cingulum of the cingulate gyrus were most consistently selected. Preoperative tract-specific FA may complement established clinical predictors of DBS outcome in PD.

20 November 2026 in Metabolic Brain Disease
Verified
Journal Article
Closed access
EKElizabeth Kouch
Elizabeth Kouch
HCHannah Chang
Hannah Chang
PSPhilip E. Shih
Philip E. Shih
ESEliette Seo
Eliette Seo
JHJenibelle Hsu
Jenibelle Hsu
EFEldo Frezza
Eldo Frezza